Drugplain

Plus Relief 6 [hp_X]/mL

NAJA NAJA VENOM · GEL · Nutra Pharma Corporation

No Recall History
Plain English

Plus Relief is a gel containing naja naja venom at 6 [hp_X]/mL, taken topical. Manufactured by Nutra Pharma Corporation.

Key Facts

Brand Name
Plus Relief
Generic Name
NAJA NAJA VENOM
NDC Code (Product)
47219-302
Manufacturer
Nutra Pharma Corporation
Strength
6 [hp_X]/mL
Dosage Form
GEL
Route
TOPICAL
Marketing Status
Marketing Start
10/28/2025

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

USE 3-4 TIMES A DAY. Note: It may take several days to induce relief. Use within 90 days of opening. Store at 50° to 80°F.

Dosage & Administration

Directions: Remove protective wrapping. Liberally apply gel to affected area. Rub thoroughly into hands and joints.

Warnings

WARNINGS: For external use only. If pain persists, consult a physician. Avoid contact with eyes. If product gets into eyes, flush with water. Seek medical attention. Not for use on open wounds. Pregnant or nursing women and children should consult a physician before use. Do not use if seal is broken prior to opening. This product is NOT intended to treat disease. It provides a temporary level of comfort, relief and a feeling of wellness.

Frequently Asked Questions

What is Plus Relief used for?

Plus Relief contains NAJA NAJA VENOM. It is a gel taken topical. Consult your doctor for specific uses.

Is Plus Relief a controlled substance?

Plus Relief is not classified as a controlled substance by the DEA.

What is the generic name for Plus Relief?

The generic name for Plus Relief is NAJA NAJA VENOM. There are 10 other brand versions of NAJA NAJA VENOM.

What is the NDC code for Plus Relief 6 [hp_X]/mL?

The NDC (National Drug Code) for Plus Relief 6 [hp_X]/mL is 47219-302, listed by Nutra Pharma Corporation.

Product NDC

47219-302

Package NDC

47219-302-08

Other Naja Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)